(2)
Company enhances patient recruitment by employing patient data for deeper visibility into test patterns and patient groups
LONDON, Dec. 16, 2020 /PRNewswire/ Based on its recent analysis of the global contract research organization (CRO) market, Frost & Sullivan recognizes LabCorp s drug development business, Covance, with the 2020 Global CRO Company of the Year Award. The company has built technology-enabled solutions to assist clients with drug development across all therapeutic areas. Its robust supply chain and logistical capabilities help scale up and efficiently manage material handling to provide clients with customized solutions, particularly for biologics drug development.
Click here to view the full multimedia release: https://best-practices.frost.com/covance/
Newswire & Press Release / Clariant Lauded by Frost & Sullivan for Addressing the Growing Customer Demand for Natural Anti - Pharma / BioTech / Nutrition - Frost & Sullivan
newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.
Newswire & Press Release / CipherHealth Recognized with Enabling Technology Leadership Award by Frost & Sullivan for its Patient Engagement - IT Services / Network Management - Frost & Sullivan
newswiretoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswiretoday.com Daily Mail and Mail on Sunday newspapers.